Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

August
08
2019

Sensus Healthcare Reports Second Quarter 2019 Financial Results

· Resumes double-digit revenue growth, up 23% over the prior year quarter · Affirms expectations for full-year double-digit revenue growth · Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 08,…

July
30
2019

Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019

BOCA RATON, Fla., July 30, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

July
23
2019

SRT & Keloid Treatment: Tony Perkins Interview

We had the pleasure of inviting patient advocate Tony Perkins to the Sensus Headquarters to tell his story of how utilizing superficial radiation therapy (SRT) as his post-operative keloid treatment help changed his life. Throughout…

July
08
2019

Dr. Pimple Popper from TLC utilizes SRT

Tune in to TLC on Thursday, July 11th at 9 est / 8 central to see Dr. Sandra Lee, otherwise known as “Dr. Pimple Popper” utilize Sensus Healthcare’s Superficial Radio Therapy (SRT) to treat one…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy